ロード中...
1,2,3,4-Tetrahydro-1,4-methanonaphthalene-2,3-diol
The title compound, C(11)H(12)O(2), is an intermediate in the synthesis of Varenicline, a nicotinic receptor partial agonist used to treat smoking addiction. In the crystal structure, there is an intramolecular O—H⋯O hydrogen bond that generates an S(5) ring motif. Intermolecular O—H⋯O hydrogen b...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
International Union of Crystallography
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2967988/ https://ncbi.nlm.nih.gov/pubmed/21581717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1107/S1600536808041068 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|